Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P KIM

Showing results (1221-1230 of 1,500) with videos related to

Pageof 150
Sort By:
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Oncogene|May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescenceJ-E Kim, J-S Shin, J-H Moon, et al.
Gastroenterology|August 14, 2012
Burden of gastrointestinal disease in the United States: 2012 updateAnne F Peery, Evan S Dellon, Jennifer Lund, et al.
Cancer Discovery|April 11, 2021
Oncogenic <i>KRAS</i> Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer MetastasisMichael P Kim, Xinqun Li, Jenying Deng, et al.
European Urology Oncology|April 25, 2019
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder CancerStephen B Williams, Hogan K Hudgins, Mohamed D Ray-Zack, et al.
Cancer Cell|May 23, 2020
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer TherapyZhentian Wang, Simone Hausmann, Ruitu Lyu, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
HER2-low expression in patients with advanced or metastatic solid tumorsB Uzunparmak, C Haymaker, G Raso, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Obesity (Silver Spring, Md.)|October 15, 2013
Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dogMarilyn Ader, Darko Stefanovski, Stella P Kim, et al.
Pageof 150

Showing results (1221-1230 of 1,500) with videos related to

Sort By:
Pageof 150
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Oncogene|May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescenceJ-E Kim, J-S Shin, J-H Moon, et al.
Gastroenterology|August 14, 2012
Burden of gastrointestinal disease in the United States: 2012 updateAnne F Peery, Evan S Dellon, Jennifer Lund, et al.
Cancer Discovery|April 11, 2021
Oncogenic <i>KRAS</i> Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer MetastasisMichael P Kim, Xinqun Li, Jenying Deng, et al.
European Urology Oncology|April 25, 2019
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder CancerStephen B Williams, Hogan K Hudgins, Mohamed D Ray-Zack, et al.
Cancer Cell|May 23, 2020
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer TherapyZhentian Wang, Simone Hausmann, Ruitu Lyu, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
HER2-low expression in patients with advanced or metastatic solid tumorsB Uzunparmak, C Haymaker, G Raso, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Obesity (Silver Spring, Md.)|October 15, 2013
Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dogMarilyn Ader, Darko Stefanovski, Stella P Kim, et al.
Pageof 150